GeoVax Labs Inc (GOVX)

[WOLDUMAR]

Welch & Forbes Owns 9.8% of GeoVax Labs - cbl
Posted February 28, 2011
Sign in to connect with your friends on Citybizlist
Share Email this Article
We Recommend...

ATLANTA -- Welch & Forbes owns 9.8 percent or 1.54 million shares of GeoVax Labs, Inc. (OTC: GOVX), according to an SEC filing.

The stake is worth $2.27 million based on Monday's closing price of $1.48.

GeoVax, whose president and CEO is Robert T. McNally, Ph.D., is an Atlanta-based biotechnology company that creates, develops, and tests HIV/AIDS vaccines.

GeoVax announced a net loss of $478,784 for the fourth quarter ended December 31, 2010, as compared to a net loss of $843,275 for the comparable period in 2009, as previously reported by citybizlist.

Led by president and portfolio manager John H. Emmons, Jr., Welch & Forbes is a wealth management firm based in Boston that provides investment portfolio management, personal trust and fiduciary services, estate planning and administration, and tax and custodial services.

SEC filing: http://tinyurl.com/4t584ld

Bio:

Robert T. McNally, Ph.D.

Dr. Robert McNally graduated with a Ph.D. in Biomedical Engineering from the University of Pennsylvania and has over 28 years of experience in academic and corporate clinical investigations, management, research, business, quality and regulatory affairs.

Dr. McNally is the President and CEO of GeoVax. Previously, he served as President as well as VP of Quality Assurance of Cell Dynamics, a company he co-founded. Cell Dynamics worked with organ and tissue procurement organizations for the recovery of human tissue processing these tissues into cellular components necessary for research and development, pharmaceuticals and cell therapy. In 1984, Dr. McNally co-founded CryoLife, Inc., a company specializing in the cryopreservation of human tissue for transplant. During his 14 year association with CryoLife, it grew to $50M in revenue, became a public company on NYSE and received world recognition as a leader in transplant technology.

He is a Fellow of the American Institute of Medical and Biological Engineers, serves on the board of the Petit Institute for Tissue Engineering at Georgia Tech and is Past Chairman of the Georgia Biomedical Partnership and recipient of its 2005 Biomedical Industry Growth Award.

Also at citybizlist, see:

GeoVax Labs Reports Q4 2010 Financial Results